Senior SEC Reporting Accountant — Public Company

Collegium Pharmaceutical, Inc.

Stoughton (MA)

Híbrido

USD 95 000 - 115 000

Tempo integral

Há 2 dias
Torna-te num dos primeiros candidatos

Recebe uma resposta deste empregador

O teu currículo e carta de apresentação, adaptados exatamente ao que estão a contratar.

Ultrapassa os filtros ATS

Resumo da oferta

Collegium Pharmaceutical, Inc. seeks a Senior Accountant, SEC Reporting, to lead the end-to-end SEC filings and equity administration. Reporting to the Assistant Controller, you will own the 10-K, 10-Q, proxy statements, and related reporting, ensuring SOX compliance and accurate equity award processing.

This role also serves as a key administrator for financial systems, partnering with IT and external auditors. The position is hybrid, based in Stoughton, MA, with relocation to Boston in 2027.

Qualificações

  • Bachelor's degree in Accounting required; CPA preferred.
  • 2–4 years of public accounting experience required; Big 4 audit experience strongly preferred.
  • Experience auditing public companies (SEC registrants) strongly preferred.
  • Strong understanding of SEC reporting requirements, including Forms 10-K and 10-Q, and U.S. GAAP.
  • Working knowledge of SOX and internal controls over financial reporting.
  • Polished, professional communication skills and comfort interacting with senior leadership.
  • Advanced, hands-on Microsoft Excel skills; experience using AI tools also preferred.

Responsabilidades

  • Perform the day-to-day SEC reporting process, including managing the preparation of the 10-K, 10-Q, annual proxy statement, and other filings as needed
  • Support the quarterly earnings process, preparing and reviewing financial information for management, the Audit Committee, and external communications
  • Support the financial statement and SOX audit process, partnering with auditors to provide timely and accurate support, establish expectations and deadlines, and manage open items lists through resolution
  • Support the SOX attestation process, including the design, implementation, and operating effectiveness of internal controls over financial reporting
  • Work with internal teams and Legal to ensure all financial and compliance processes for the Company's equity plan, including W-2 and 1099 reporting impacts, Employee Stock Purchase Plan (ESPP) enrollment, Restricted Stock Unit (RSU) processing, and overall administration of employee equity awards
  • Develop and implement enhancements to the financial close and equity administration processes with support from consultants and colleagues
  • Serve as a key administrator and reviewer for the Company's accounting and finance systems and related reports
  • Work closely with the accounting team to identify opportunities to improve the accuracy, timeliness, and effectiveness of financial reporting
  • Identify opportunities to develop and use analytics that turn data into actionable information
  • Partner with other departments to ensure effective use of systems, Excel models and AI tools, reporting, and information sharing, as well as overall compliance with internal controls
  • Build strong relationships with colleagues across functions, including Finance, Legal, HR, IT, R&D, Operations, and Sales & Marketing
  • Communicate clearly, providing thoughtful explanations and asking clarifying questions
  • Drive continuous improvement and proactively solve routine problems

Conhecimentos

SOX compliance
SEC reporting
Financial analysis
Cross-functional communication
Auditing

Formação académica

Bachelor's degree in Accounting
CPA preferred

Ferramentas

Microsoft Excel
AI tools

Descrição da oferta de emprego

Collegium Pharmaceutical, Inc. seeks a Senior Accountant, SEC Reporting, to lead the end-to-end SEC filings and equity administration. Reporting to the Assistant Controller, you will own the 10-K, 10-Q, proxy statements, and related reporting, ensuring SOX compliance and accurate equity award processing.

This role also serves as a key administrator for financial systems, partnering with IT and external auditors. The position is hybrid, based in Stoughton, MA, with relocation to Boston in 2027.

Obtém a tua avaliação gratuita e confidencial do currículo.

ou arrasta e larga o ficheiro aqui.

Similar jobs

Ofertas semelhantes que vale a pena comparar

Hybrid Senior SEC Reporting Accountant
Hybrid Senior SEC Reporting Accountant

Collegium Pharmaceutical, Inc. • Stoughton (MA)

Híbrido
USD 95 000 - 115 000
Senior SEC Reporting Accountant — Hybrid (Boston)
Senior SEC Reporting Accountant — Hybrid (Boston)

Collegium-Pharmaceutical,-Inc • Stoughton (MA)

Híbrido
USD 95 000 - 115 000
Hybrid work model
Onsite Tue-Thu
Senior Accountant, SEC Reporting & Equity Administration
Senior Accountant, SEC Reporting & Equity Administration

Collegium Pharmaceutical, Inc. • Boston (MA)

Híbrido
USD 95 000 - 115 000
Senior Accountant SEC Reporting
Senior Accountant SEC Reporting

Collegium Pharmaceutical, Inc. • Stoughton (MA)

Híbrido
USD 95 000 - 115 000
Senior Accountant SEC Reporting
Senior Accountant SEC Reporting

Collegium Pharmaceutical, Inc. • Boston (MA)

Híbrido
USD 95 000 - 115 000
Senior Accountant SEC Reporting New Boston, MA
Senior Accountant SEC Reporting New Boston, MA

Collegium Pharmaceutical, Inc. • Stoughton (MA)

Híbrido
USD 95 000 - 115 000
Senior SEC Accountant
Senior SEC Accountant

Selby Jennings • Austin (TX)

Presencial
USD 115 000 - 118 000
Biopharma SEC Reporting & Equity Accounting Lead
Biopharma SEC Reporting & Equity Accounting Lead

Neurocrine Biosciences • San Diego (CA)

Híbrido
USD 120 000 - 180 000
Senior Director, SEC Reporting & SOX — Hybrid (Biotech)
Senior Director, SEC Reporting & SOX — Hybrid (Biotech)

Klein Hersh International • Boston (MA)

Presencial
USD 180 000 - 240 000
SEC Reporting & Equity Accounting Manager
SEC Reporting & Equity Accounting Manager

Neurocrine Biosciences • San Diego (CA)

Presencial
USD 120 000 - 180 000